4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
2 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
9. 33
-0.33
-3.42%
$
492.74M Market Cap
- P/E Ratio
- Div Yield
1,511,673 Volume
-3.06 Eps
$ 9.66
Previous Close Day Range
8.96 9.74
Year Range
2.23 12.34
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
FDMT earnings report is expected in 64 days (6 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
FDMT Earnings Reports FAQ
What is the earnings per share (EPS) for FDMT?
The current EPS is -3.06.
What is the company's earnings growth rate?
4D Molecular Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-06, based on the FDMT's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for 4D Molecular Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for FDMT at this time, as 4D Molecular Therapeutics, Inc has no recent EPS data to calculate it.
